Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-04

Clinical Trial Update: Efficacy of External Application of Rosemary Oil in Patients With Chemotherapy-Induced Peripheral Neuropathy: a Feasibility Study [NA]

View source ↗

Summary

A completed feasibility study evaluated whether topical rosemary oil can reduce symptoms of chemotherapy-induced peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosemary oil (Rosemary oil)

Snippet

Sponsor: ARCIM Institute Academic Research in Complementary and Integrative Medicine | Conditions: Chemotherapy-induced Peripheral Neuropathy (CIPN) | NA | Status: COMPLETED